4 results on '"B, Demontis"'
Search Results
2. PD-0481: Local control and cosmetic outcome on 100 early breast cancer treated with exclusive IORT
- Author
-
B. Demontis, G. Murenu, Grosso Lp, M. Dessi, S. Porru, M. Dessena, and G. Gambula
- Subjects
Oncology ,medicine.medical_specialty ,Radiology Nuclear Medicine and imaging ,business.industry ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business ,Outcome (game theory) ,Early breast cancer - Published
- 2015
- Full Text
- View/download PDF
3. Exclusive I.O.R.T. for early stage breast cancer: Results after 93 cases using GEC-ESTRO criteria
- Author
-
G. Gambula, M. Dessena, Giancarlo Lay, G. Murenu, M. Dessi, S. Porru, M. Fiorbelli, Grosso Lp, and B. Demontis
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,General surgery ,Mortality rate ,General Medicine ,medicine.disease ,Radiation therapy ,Breast cancer ,Internal medicine ,medicine ,Surgery ,Stage (cooking) ,Hepatectomy ,Radical surgery ,business ,Survival rate ,Quadrantectomy - Abstract
S S11 Exclusive I.O.R.T. for early stage breast cancer: Results after 93 cases using GEC-ESTRO criteria G. Gambula*, M. Dessena, B. Demontis, L.P. Grosso, S. Porru, M. Dess i, M. Fiorbelli, G. Lay, G. Murenu 1 Oncology Hospital UOC Experimental Surgery, Cagliari, Italy Oncology Hospital UOC Health Physics, Cagliari, Italy Oncology Hospital UOC Oncologic Radiotherapy, Cagliari, Italy * Corresponding author: Giuseppe Gambula, Oncology Hospital UOC Experimental Surgery, Cagliari, Italy. E-mail address: gambul75@yahoo.it (G. Gambula) Study objectives: To evaluate feasibility, tolerability, cosmetic outcome and local control of intra-operative radiation therapy (IORT) as an exclusive treatment of early stage breast cancer in patients selected according to GEC-ESTRO criteria (good candidates). Materials and methods: From October 2008 to December 2013, 93 patients underwent wide breast cancer excision or quadrantectomy followed by IORT on tumor bed with accelerated electrons (Novac 7 NRT) at the dose of 21Gy. Patients were aging at least 50 years with unicentric, unifocal, pT1-2 ( 5) associated to occurrence of major morbidity after the first-step were predictive factors of second-step failure. Major hepatectomy with the need of transfusion in pts who received more than 8 cycles of (bio)chemotherapy were associated to significant postoperative morbidity. The overall mortality rate after liver resection was 9%. The overall 3eyear survival rate in pts who underwent complete radical liver surgery were 65% versus 0% for those who could not undergo radical surgery. Conclusion: The results suggest that in highly selected pts with initially not easily resectable LM from CRC, radical (one or two-step) hepatectomy can increase the 3-year survival rate after down-sizing biochemotherapy with consequent mortality. http://dx.doi.org/10.1016/j.ejso.2014.10.031 Long-term follow up in patients with IPMN-branch duct type (BDT) not submitted to surgery S. Molfino*, G.L. Baiocchi, N. Portolani, M. Bartoli, D. Lomiento, G. Merigo, S.M. Giulini Surgical Clinic, University of Brescia, Brescia, Italy * Corresponding author: Sarah Molfino, Brescia, Italy. E-mail address: sarahmolfino@gmail.com (S. Molfino) Study objective: Even if International Guidelines contemplate surgery for IPMN-BDT larger than 3 cm of diameter, with wall-thickness >3 mm, with parietal nodules, however some data suggest that a lot of these tumors could only be followed-up. The aim of this article is to analyze the implications of long-term follow-up in patients with IPMN-BDT not submitted to surgery, with particular attention on clinical and morphological evolution. Material and methods: During the period 2006e2011, two-hundred and thirty-four patients with IPMN have been observed. Surgery was directed to patients with IPMN MDT and BDT + MDT (92 patients) and to other 13 patients with IPMN-BDT with a strong suspect of malignancy (by cytology with EUS and/or 18FDG-PET), independently from Sendai Criteria.
- Published
- 2015
- Full Text
- View/download PDF
4. Reconstructive surgery in operable breast cancer. Critical evaluation
- Author
-
G. Murenu, L. Maktino, S. Licheri, and B. Demontis
- Subjects
Adult ,medicine.medical_specialty ,Reconstructive surgery ,Time Factors ,medicine.medical_treatment ,Mammaplasty ,Breast Neoplasms ,Free flap ,Prosthesis ,General Biochemistry, Genetics and Molecular Biology ,Breast cancer ,History and Philosophy of Science ,medicine ,Humans ,Neoplasm Invasiveness ,Mastectomy ,Modalities ,business.industry ,General Neuroscience ,General surgery ,Carcinoma ,Prostheses and Implants ,medicine.disease ,Sample group ,Tram flap ,Female ,business ,Breast carcinoma - Abstract
In a large number of patients suffering from breast carcinoma the surgeon is still forced, for strictly technical reasons and/or by the patient's choice, to perform a radical operation that psychologically and practically compromises the quality of life of the patient, in varying degrees from patient to patient. The authors have analyzed the main characteristics of BR from the esthetic-functional, psychological, and oncological points of view, in the light of a careful examination of the literature and of the data relating to a sample group of 500 BR treated according to a protocol in which BR has been included, with times and modalities depending on the histological type of tumor and the level of local evolution of the disease. The variety of BR techniques available is such as to permit this option in a great variety of cases. Whenever possible, immediate BR, with placement of a breast prosthesis at the same time or after positioning a tissue expander, is to be preferred. If additional skin or muscle is needed, BR is to be performed at a later time by means of more complex techniques (latissimus dorsi myocutaneous flap plus prosthesis, TRAM flap, free flap). When performed after adequate evaluation and in a technically valid way, BR gives good esthetic and psychological results, has a low incidence of complications or sequelae, and does not affect the natural history of the disease; in particular, BR does not change the percentage of local recurrence or its early diagnosis and allows adequate multidisciplinary treatment.
- Published
- 1993
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.